Benzenoids
![Medchemexpress LLC 1-[4-[(2S)-2-(morpholin-4-ylmethyl)pyrrolidin-1-yl]sulfonylphenyl]-3-[4-(trifluoromethyl)phenyl]urea | 2230496-99-6 | 99.9% | 512.55 | C23H27F3N4O4S | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000221409.png-250.jpg)
Medchemexpress LLC 1-[4-[(2S)-2-(morpholin-4-ylmethyl)pyrrolidin-1-yl]sulfonylphenyl]-3-[4-(trifluoromethyl)phenyl]urea | 2230496-99-6 | 99.9% | 512.55 | C23H27F3N4O4S | 5 MG
ZL0590 is a potent, orally active small-molecule inhibitor selective for the BRD4 BD1 bromodomain. It has an IC50 of approximately 90 nM against human BRD4 BD1 and demonstrates anti-inflammatory efficacy in preclinical models, making it suitable for research into bromodomain biology and inflammatory disease mechanisms.
- Potent BRD4 BD1 inhibition (IC50 ≈ 90 nM)
- Selective for BD1 over other bromodomains
- Demonstrated anti-inflammatory activity in animal models
- Appropriate for in vitro and in vivo research applications
- Soluble in DMSO for solution preparation
- High chemical purity (~99.9%)
Medchemexpress LLC 3-(benzyl(isopropyl)amino)-1-(naphthalen-2-yl)propan-1-one hydrochloride | 1021868-92-7 | MFCD04974534 | >98.0% | 367.91 g/mol | C23H26ClNO | 10MM 1ML
ZM39923 hydrochloride is a small-molecule JAK3 inhibitor used in research. It displays JAK3 potency (pIC50 = 7.1) and also inhibits tissue transglutaminase (TGM2) with an IC50 of 10 nM; it is supplied as a 10 mM solution in DMSO and in solid quantities.
- Small-molecule JAK3 inhibitor (pIC50 = 7.1).
- Potent TGM2 inhibition (IC50 = 10 nM).
- Available as 10 mM solution in DMSO and in solid forms.
- Molecular formula C23H26ClNO.
- Molecular weight 367.91 g/mol.
- Purity >98.0% by HPLC.
- For research use only.
Medchemexpress LLC Methanone, bis(2,4-dihydroxyphenyl)- | 131-55-5 | MFCD08692012 | 99.7% | 246.22 g/mol | C13H10O5 | 50 G
Benzophenone-2 (2,2',4,4'-tetrahydroxybenzophenone) is a research-grade UV-filter compound used to study nuclear receptor activation and CYP3A regulation. It modulates the pregnane X receptor (PXR) and estrogen receptor α (ERα) and is intended for laboratory research use only, not for clinical or human use.
- Acts as an endocrine disruptor targeting PXR and ERα.
- High purity suitable for analytical and research applications.
- Molecular formula C13H10O5; molecular weight 246.22 g/mol.
- Available in multiple pack sizes to support varied experimental needs.
- Supplied with batch-specific certificate of analysis for quality verification.
![Alkali Scientific LB Broth [Lennox] Powder, 2 Kg](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000661200.jpg-250.jpg)
Alkali Scientific LB Broth [Lennox] Powder, 2 Kg
LB Broth (Lennox) Powder, 10kg, is designed for high-volume applications in microbiology and molecular biology labs. This high-performance medium supports the growth of a wide range of bacterial species, particularly Escherichia coli, which is commonly used in genetic engineering and cloning studies. The Lennox formulation offers a balanced nutrient profile that ensures optimal bacterial growth while maintaining the simplicity and cost-effectiveness of standard LB media. This medium is widely used in recombinant DNA research, protein expression, and general bacterial culture for laboratory applications. The powder form provides flexibility and convenience in large-scale preparations.
Medchemexpress LLC L-pyrohomoglutamic acid | 34622-39-4 | MFCD03839863 | 97.0% | 143.14 g·mol⁻¹ | C6H9NO3 | 5 G
L-pyrohomoglutamic acid is a non-proteinogenic amino acid used as a synthetic building block in medicinal chemistry and biochemical research. It is employed as an intermediate for preparing ligands targeting FK506-binding proteins (FKBPs) and histone deacetylase (HDAC) inhibitors, and is supplied as a purified powder for laboratory use.
- High purity (~97%) suitable for research applications.
- Used as a building block for FKBP and HDAC ligand synthesis.
- Molecular formula C6H9NO3 and molecular weight 143.14 g·mol⁻¹.
- Available in lab-scale pack sizes for synthetic and analytical workflows.
- Provided with product documentation including COA and SDS for quality assurance.
eMolecules (S)-1-(4-BROMOPHENYL)-2,2,2-TRIFLUOROETHANAMINE | 778565-93-8 | MFCD07374593 | 1g
AstaTech | (S)-1-(4-BROMOPHENYL)-2,2,2-TRIFLUOROETHANAMINE | 1g | 386841143 | 66352 | 95.000 | 778565-93-8 | MFCD07374593 | 254.050 | C8H7BrF3N
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules (1R)-1-(3-BROMOPHENYL)-2,2,2-TRIFLUOROETHYLAMINE | 843608-54-8 | MFCD07374617 | 1g
AstaTech | (1R)-1-(3-BROMOPHENYL)-2,2,2-TRIFLUOROETHYLAMINE | 1g | 410713703 | F16857 | 95.000 | 843608-54-8 | MFCD07374617 | 254.050 | C8H7BrF3N
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
![Medchemexpress LLC Trans-N,N-bis[2-chlorophenylmethyl]-1,4-cyclohexanedimethanamine dihydrochloride | 366-93-8 | MFCD01734586 | 99.7% | 464.30 g/mol | C22H30Cl4N2 | 10 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000239898.png-250.jpg)
Medchemexpress LLC Trans-N,N-bis[2-chlorophenylmethyl]-1,4-cyclohexanedimethanamine dihydrochloride | 366-93-8 | MFCD01734586 | 99.7% | 464.30 g/mol | C22H30Cl4N2 | 10 MG
AY 9944 dihydrochloride is a research-grade small molecule that selectively inhibits 7-dehydrocholesterol Δ7-reductase (DHCR7), disrupting cholesterol biosynthesis for biochemical and cellular studies. Supplied as a solid dihydrochloride salt with high purity, it is intended for laboratory research use where potent, reproducible DHCR7 inhibition is required.
- Inhibits DHCR7 with an IC50 of 13 nM.
- High purity (~99.7%) suitable for analytical and biological assays.
- Solid dihydrochloride form for convenient handling and weighing.
- Soluble in DMSO and water; sonication may be required.
- Stable when stored sealed at 4°C; stock solutions stable at -20°C to -80°C.
- Commonly used to model cholesterol biosynthesis inhibition in vitro and in vivo.
eMolecules 4-(4-AMINOPHENOXY)BENZOIC ACID | 28999-69-1 | MFCD00446982 | 1g
AstaTech | 4-(4-AMINOPHENOXY)BENZOIC ACID | 1g | 392628380 | AB6086 | 95.000 | 28999-69-1 | MFCD00446982 | 229.235 | C13H11NO3
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Cdk2-in-4 | 2079895-42-2 | MFCD32174273 | 99.9% | 442.49 g/mol | C23H18N6O2S | 1 ML
CDK2-IN-4 is a potent, selective small-molecule inhibitor of cyclin-dependent kinase 2 (CDK2). It inhibits CDK2/cyclin A with an IC50 of 44 nM and shows approximately 2,000-fold selectivity over CDK1/cyclin B (IC50 = 86 μM). The compound is intended for research use in cell-cycle and cancer biology studies.
- Potent CDK2 inhibition (IC50 = 44 nM).
- High selectivity versus CDK1 (≈2,000-fold; CDK1 IC50 = 86 μM).
- Supplied as a 10 mM solution in DMSO (1 mL) and as solid material in multiple package sizes.
- Molecular weight 442.49 g/mol; chemical formula C23H18N6O2S.
- Datasheet and safety data sheet available for laboratory handling and safety information.
Medchemexpress LLC Sanfetrinem sodium | 141611-76-9 | 95.0% | 303.29 g·mol⁻1 | C14H18NNaO5 | 1 MG
Sanfetrinem sodium is the sodium salt of sanfetrinem, a beta-lactamase-stable, broad-spectrum antibiotic supplied as a solid research compound for in vitro and related studies.
- Provides beta-lactamase-stable broad-spectrum antibacterial activity.
- CAS number 141611-76-9.
- Molecular formula C14H18NNaO5; molecular weight 303.29 g·mol⁻1.
- Supplied as a solid sodium salt suitable for laboratory research.
- Typical purity (NMR) 95.0% as reported on the certificate of analysis.
- Available in small pack sizes for screening and analytical use.
Medchemexpress LLC (R)-WM-586 | C20H20F3N5O3S | 1 MG
(R)-WM-586 is the R-enantiomer of WM-586, functioning as a covalent WDR5 inhibitor. This compound is primarily utilized in research for various cancers, including neuroblastoma, breast cancer, bladder cancer, and colorectal cancer, by specifically decreasing the interaction between WDR5 and MYC.
- Functions as a covalent WDR5 inhibitor
- Specifically decreases WDR5 and MYC interaction with an IC50 of 101 nM
- Used in research for various cancers
- Does not affect the binding of WDR5 to RBBP5